FULL-TEXT ARTICLE
Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid
Epidemic.
Liang TJ, Ward JW.
N Engl J Med.
2018 Mar 29;378(13):1169-1171.
Paper
FULL-TEXT ARTICLE
Potential geographic "hotspots" for drug-injection related transmission of HIV
and HCV and for initiation into injecting drug use in New York City, 2011-2015,
with implications for the current opioid epidemic in the US.
Des Jarlais DC, Cooper HLF, Arasteh K, et al
PLoS One.
2018 Mar 29;13(3):e0194799.
Paper
The next wave of hepatitis C virus: The epidemic of intravenous
drug use.
Shiffman ML.
Liver Int. 2018 Feb;38 Suppl 1:34-39.
Abstract
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid
Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.
Zibbell JE, Asher AK, Patel RC,
ey al
Am J Public Health. 2017 Dec
21:e1-e7.
Abstract
Seroprevalence of HCV and HIV infection among clients of the nation's
longest-standing statewide syringe exchange program: A cross-sectional study of
Community Health Outreach Work to Prevent AIDS (CHOW) Project participants,
Hawai'i, 2012.
Salek TP, Katz AR, Lenze SM,
et
al
Int J Drug Policy. 2017 Aug 2;48:34
Abstract
Cross-border injection drug use and HIV and hepatitis C virus
seropositivity among people who inject drugs in San Diego, California.
Horyniak D, Wagner KD, Armenta RF, et al
Int J Drug Policy. 2017 Jul 3;47:9-17.
Abstract
State HCV Incidence and Policies Related to HCV Preventive and
Treatment Services For Persons Who Inject Drugs - United States, 2015-2016.
Campbell CA, Canary L, Smith N, et al
Am J Transplant. 2017 Jul;17(7):1945-1948.
Abstract
FULL-TEXT ARTICLE
State HCV
Incidence and Policies Related to HCV Preventive and Treatment Services for
Persons Who Inject Drugs - United States, 2015-2016.
Campbell CA, Canary L, Smith N, et al
MMWR
Morb Mortal Wkly Rep. 2017 May 12;
Paper
"It's Not What You Know but Who You Know": Role of Social Capital
in Predicting Risky Injection Drug Use Behavior in a Sample of People who
Inject Drugs in Baltimore City.
Kumar PC, McNeely J, Latkin CA.
J Subst Use. 2016;21(6):620-626.
Abstract
County-Level Vulnerability Assessment for Rapid Dissemination
of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
Van Handel MM, Rose CE, et alJ
Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331.
Abstract
The Shift in Emphasis From Risk-Based to Age-Based
Hepatitis C Virus (HCV) Testing in the US Tends to Remove Injection Drug
Use From Discourse on HCV.
Jordan AE, Perlman DC.
Subst Use Misuse. 2016
Oct 21:
Abstract
High-impact hepatitis C virus testing for injection drug users in an
urban ED.
Anderson ES, Pfeil SK, Deering LJ,
et al
Am J Emerg Med. 2016
Mar 3.
Abstract
FULL-TEXT ARTICLE
Agent-Based Model Forecasts Aging of the Population of People Who Inject
Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C
Infections.
Gutfraind A, Boodram B, Prachand N,
et al;
PLoS One. 2015 Sep
30;10(9):e0137993.
Paper
Dead space in over-the-counter syringes: The implications for
HIV and HCV transmission.
Oramasionwu CU, Bailey SC, Moore HN, et al
Int J Drug Policy.
2015 Aug 13.
Abstract
FULL-TEXT ARTICLE
Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral
Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.h
Echevarria D, Gutfraind A, Boodram B, et al
PLoS One. 2015 Aug
21;10(8):e0135901.
Paper
Opioid Use Trajectories, Injection Drug Use and HCV Risk among
Young Adult Immigrants from the Former Soviet Union Living in New York City.
Guarino H, Marsch LA, Deren S,
et al
J Addict Dis. 2015 Jul 1:0.
Abstract
Associations between prescription opioid injection and Hepatitis
C virus among young injection drug users.
Lankenau S, Kecojevic A, Silva K.
Drugs (Abingdon Engl). 2015;22(1):35-42.
Abstract
Awareness of HCV Infection Among Persons Who Inject Drugs in San
Diego, California.
Collier MG, Bhaurla SK, Cuevas-Mota J, et al
Am J Public Health. 2014 Dec
18:e1-e2
Abstract
FULL-TEXT ARTICLE
Intimate Injection Partnerships Are at Elevated Risk of High-Risk Injecting: A
Multi-Level Longitudinal Study of HCV-Serodiscordant Injection Partnerships in
San Francisco, CA.
Morris MD, Evans J, Montgomery M, et al
PLoS One. 2014 Oct
6;9(10):e109282.
Paper
Risk Factors for HCV Infection Among Young Adults in Rural New
York Who Inject Prescription Opioid Analgesics.
Zibbell JE, Hart-Malloy R, Barry J,
et al
Am J Public Health. 2014 Sep 11:e1 al
Abstract
Emerging Epidemic of Hepatitis C Virus Infections Among Young
Non-Urban Persons who Inject Drugs in the United States, 2006-2012.
Suryaprasad AG, White
JZ, Xu F, et al
Clin Infect Dis. 2014 Aug
11. pii: ciu643
Abstract
Concordance of risk behavior reporting within HCV serodiscordant
injecting partnerships of young injection drug users in San Francisco, CA.
Evans JL, Morris MD, Yu M, Page K, Hahn JA.
Drug Alcohol Depend. 2014 Jul 4.
Abstract
Hepatitis C Prevention and Needle Exchange Programs in Rhode
Island: ENCORE.
Joseph R, Kofman A, Larney S, Fitzgerald P.
R I Med J (2013). 2014 Jul 1;96(7):31-4.
Abstract
Unmet Health Care Needs and Hepatitis C Infection Among Persons
Who Inject Drugs in Denver and Seattle, 2009.
Al-Tayyib AA, Thiede H, Burt RD, Koester S.
Prev Sci.
2014 Jun 27.
Abstract
FULL TEXT ARTICLE
Higher risk of
incident hepatitis C virus among young women who inject drugs compared with
young men in association with sexual relationships: a prospective analysis from
the UFO Study cohort.
Tracy D, Hahn JA, Fuller Lewis C, et al
BMJ Open. 2014 May 29;4(5):e004988
Paper
FULL TEXT ARTICLE
Estimating the Number of Persons Who Inject Drugs in the United States by
Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus
Infections.
Lansky A, Finlayson T, Johnson C, et al
PLoS One. 2014 May 19;9(5):e97596.
Paper
Hepatitis C Virus-Related Knowledge and Willingness to
Receive Treatment Among Patients on Methadone Maintenance.
Zeremski M, Dimova RB, Zavala R, et al
J Addict Med.
2014 May 9.
Abstract
Confronting the Emerging Epidemic of HCV Infection Among Young Injection
Drug Users.
Valdiserri R, Khalsa J, Dan C, et al
Am J Public Health.
2014 Mar 13.
Abstract
Transitions from injecting to non-injecting drug use: Potential protection against HCV infection.
Des Jarlais DC, McKnight C, Arasteh K, et al
J Subst Abuse Treat. 2014 Mar;46(3):325-31.
Abstract
Barriers and facilitators of hepatitis C screening among people who inject
drugs: a multi-city, mixed-methods study.
Barocas
JA, Brennan MB, Hull SJ, et al
Harm Reduct J. 2014 Jan
14;11(1):
Abstract
"To Share or Not to Share?" Serosorting by Hepatitis C Status in
the Sharing of Drug Injection Equipment Among NHBS-IDU2 Participants.
Smith BD, Jewett A, Burt RD, et al
J Infect Dis. 2013 Dec;208(12):1934-42
Abstract
Hepatitis C virus control among persons who inject drugs requires
overcoming barriers to care.
Zeremski M, Zibbell JE, Martinez AD, et al
World J Gastroenterol.
2013 Nov 28;19(44):7846-7851
Abstract
Hepatitis-C Multimedia Prevention Program in Poor Hispanic
HIV-Infected Injecting drug users: Six Months after Intervention.
Mayor AM, Fernández DM, Colón CM,
et al
J Health Care Poor Underserved. 2013
Nov;24(4 Suppl):29-37
Abstract
Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in
Connecticut: Understanding Infection and Coinfection Risks in a Nonurban
Population.
Akselrod H, Grau LE, Barbour R, Heimer R.
Am J Public Health.
2013 Oct 17.
Abstract
"To share or not to share?" Serosorting by hepatitis C status in the
sharing of drug injection equipment among NHBS-IDU2 participants.
Smith BD, Jewett A,
Burt RD, et al
J Infect Dis. 2013 Oct 16.
Abstract
Injection drug use and hepatitis C virus infection in young adult
injectors: using evidence to inform comprehensive prevention.
Page K, Morris MD, Hahn JA, et al
Clin Infect Dis. 2013
Aug;57 Suppl 2:S32-8.
Abstract |
Missed Opportunities for Hepatitis C Testing in Opioid Treatment
Programs.
Frimpong JA.
Am J Public Health. 2013 Apr 18
Abstract
Predictors of Active Injection Drug Use in a Cohort of Patients
Infected With Hepatitis C Virus.
Reed C, Bliss C, Stuver SO,
et al
Am J Public Health. 2013
Jan;103(1):105-111
Abstract
Individual and Network Factors Associated With Prevalent
Hepatitis C Infection Among Rural Appalachian Injection Drug Users.
Havens JR, Lofwall MR, Frost SD, et al
Am J Public Health. 2013
Jan;103(1):e44-e52
Abstract
Predictors of Active Injection Drug Use in a Cohort of Patients
Infected With Hepatitis C Virus.
Reed C, Bliss C, Stuver SO,
et al
Am J Public Health. 2012 Nov 15
Abstract |
Frequent longitudinal sampling of HCV infection in IDU reveals
intermittently detectable viremia and reinfection
Page K, Osburn W, Evans J,
et al
Clin Infect Dis. 2012 Oct
22
Abstract
A simple strategy to identify acute HCV infection among newly
incarcerated injection drug users.
Kim AY, Nagami EH, Birch CE,
et al
Hepatology. 2012 Oct 30.
Abstract
FULL-TEXT
ARTICLE
Cost
Effectiveness of Screening Strategies for Early Identification of HIV and HCV
Infection in Injection Drug Users.
Cipriano LE, Zaric GS, Holodniy M,et al
PLoS One.
2012;7(9):e45176
Paper
Concurrent group treatment for hepatitis C: Implementation and
outcomes in a methadone maintenance treatment program.
Stein MR, Soloway IJ, Jefferson KS,
et al
J Subst Abuse Treat. 2012 Oct
Abstract
HCV Infection Prevalence Lower Than Expected among
18-40-Year-Old Injection Drug Users in San Diego, CA.
Garfein RS, Rondinelli A, Barnes RF,et
al
J Urban Health. 2012 Jul 6.
Abstract
Resilience Among IDUs: Planning Strategies to Help Injection Drug Users to
Protect Themselves and
Others From HIV/HCV Infections.
Sirikantraporn S, Mateu-Gelabert P,
et al
Subst Use Misuse. 2012 May 10.
Abstract |
Field-based performance of three pre-market rapid hepatitis
C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk)
among young adults who inject drugs in San Diego, CA.
Jewett A, Smith BD, Garfein RS,
et al
J Clin Virol. 2012 May 3.
Abstract
Injection behaviors among injection drug users in treatment: The role of
hepatitis C awareness.
Korthuis PT, Feaster DJ, Gomez ZL, et al
Addict Behv. 2011 Dec 14
Abstract |
Meta-Analysis of Hepatitis C Seroconversion
in Relation to Shared Syringes and Drug Preparation
Equipment.
Pouget ER, Hagan H, Des Jarlais DC.
Addiction. 2011 Dec 13.
Abstract
CXCL9 and CXCL10 Chemokines as Predictors of Liver Fibrosis in a Cohort of
Primarily African-American
Injection
Drug Users With Chronic Hepatitis C.
Zeremski M, Dimova R, Astemborski J,
et al
J Infect Dis. 2011 Sep;204(6):832-6.
Abstract
Prevalence of HCV risk behaviors among prison inmates: tattooing
and injection drug use.
Peña-Orellana M, Hernández-Viver A,
et al
J Health Care Poor Underserved.
2011;22(3):962-82.
Abstract
Associations Between Herpes Simplex Virus Type 2 and HCV With HIV Among
Injecting Drug Users in New York City.
Des Jarlais D, Arasteh K, McKnight C,
et al
Am J Public Health. 2011 May 12
Abstract
Diagnosis of depression in former injection drug users with chronic
hepatitis C.
Scott JD, Wang CC, Coppel E,
et al
J Clin Gastroenterol. 2011
May-Jun;45(5):462-7.
Abstract
Assessing Candidacy for Acute Hepatitis C Treatment Among Active Young
Injection Drug Users:
A Case-Series Report.
Asher A, Lum PJ, Page K.
J Assoc Nurses AIDS Care.
2011 Apr 14
Abstract
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
IDU
HCV
National Studies
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader